tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Charles Duncan, 389 are a BUY (89.84%), 40 are a HOLD (9.24%), 4 are a SELL (0.92%).
Analyst Charles Duncan, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 46.79% that have a potential upside of 52.71% achieved within 305 days. Previously, Charles Duncan worked at PIPER SANDLER.
Charles Duncan’s has documented 846 price targets and ratings displayed on 59 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on BHVN, Biohaven Pharmaceutical Holding Co Ltd at 17-Dec-2024.
Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 3/3/2020. The price target of $144 was fulfilled within 3 days with a profit of $54.6 (61.07%) receiving and performance score of 203.58.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$22
$1.96 (9.78%)
$24
10 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Hold
$20
$-0.04 (-0.20%)
$25
1 months 18 days ago
(03-Jan-2025)
5/6 (83.33%)
$1.59 (8.64%)
172
Buy
$27
$6.96 (34.73%)
$27
3 months 14 days ago
(07-Nov-2024)
7/20 (35%)
$9.8 (56.98%)
118
Buy
$28
$7.96 (39.72%)
$28
3 months 14 days ago
(07-Nov-2024)
0/5 (0%)
$10.8 (62.79%)
Hold
4 months 11 days ago
(10-Oct-2024)
11/14 (78.57%)
$9.98 (39.89%)
141
Which stock is Charles Duncan is most bullish on?
Which stock is Charles Duncan is most reserved on?
What Year was the first public recommendation made by Charles Duncan?
